ABOUT US
关于我们
Dr. Zhican Qu
Chairman and Chief Scientist of Nanolattix Group
Dr. Qu received her bachelor's and master's degrees from Tsinghua University and her Ph.D. from the Johns Hopkins University; Dr. Qu completed her Postdoctoral fellowship in Washington University Medical School.
Dr. Qu was a Principal Investigator (PI) leading a drug discovery program in Southern Research Institute (SRI), focused on anti-cancer R&D.
Over 30 years, Dr. Qu has accumulated extensive experience in the field of cancer research and anti-cancer drug development. Currently, Dr. Qu is leading Nanolattix Group focusing on Antibody Drug Conjugates (ADC) and Radionuclide Drug Conjugates (RDC) drug development.
